{"id":287206,"date":"2026-10-05T14:33:07","date_gmt":"2026-10-05T09:03:07","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=287206"},"modified":"2026-10-05T14:33:07","modified_gmt":"2026-10-05T09:03:07","slug":"pfizer-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pfizer-best-stock-in-its-sector\/","title":{"rendered":"Is Pfizer the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"

Pfizer CMP Rs 3,836 (05 Oct 2026). Market cap Rs 17,636 Cr. ROE 17.19%. P\/E 23.99x versus Industry P\/E 50.45x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Pfizer is one of the names investors compare when screening the Healthcare sector, built on a 17.19% return on equity and a P\/E of 23.99x against an Industry P\/E of 50.45x. Whether Pfizer is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n

Is Pfizer<\/a> the best stock in its sector? The stock trades on the NSE at Rs 3,836 as of 05 October 2026, within its 52-week range of Rs 3,792.10 to Rs 5,578.50. Pfizer Ltd is the listed Indian arm of Pfizer Inc and sells prescription pharmaceuticals and vaccines in India.<\/p>\n

Pfizer sits in the Healthcare sector, and its 17.19% ROE and 23.99x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P\/E benchmark.<\/p>\n

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n